Financial Performance - Illumina's Q3 2025 revenue was $1.08 billion, approximately flat year-over-year in constant currency and reported terms[8] - Non-GAAP operating margin was 24.5%[8] - Non-GAAP diluted EPS reached $1.34, an 18% increase[8, 31] - Free cash flow for Q3 2025 was $253 million[33, 34, 35] Revenue Breakdown - Sequencing consumables revenue was $747 million, a 1% increase[16] - Sequencing instruments revenue was $107 million, a 3% increase[28] - Sequencing service and other revenue was $147 million, a 2% decrease[28] - Revenue excluding Greater China grew by approximately 2% year-over-year in constant currency[8] Regional Performance - Americas revenue was $612 million, a 1% increase[8] - Europe revenue was $309 million, a 6% increase[8] - AMEA (Asia Pacific, Middle East and Africa) revenue was $111 million, a 6% increase[8] - Greater China revenue was $52 million, a 31% decrease[8] NovaSeq X Transition - Over 50% of high-throughput revenue was attributed to NovaSeq X[8, 13, 21] - Over 75% of high-throughput gigabases shipped were attributed to NovaSeq X[13, 21] FY25 Guidance - Illumina anticipates full year 2025 revenue growth between 0% and 1% for the rest of the world and between -1.5% and -0.5% for Greater China[37] - The company projects full year revenue between $427 billion and $431 billion[37]

Pipeline Highlights - MP0712 (212Pb x DLL3) IND-enabling studies completed, IND filed[15] - Strategic collaboration with Orano Med expanded to ten 212Pb programs[15] - Lead candidate MP0726 targeting mesothelin (MSLN) nominated based on pre-clinical data[15] - Improved response rate and antitumor activity in low disease burden patients of ongoing Phase 1/2a reported for MP0533 at EHA 2025[15] - Study protocol approved for combo IIT with standard-of-care in cholangiocarcinoma for Switch-DARPin MP0317[15] Financial Position - The company has CHF ~105 million in cash as of September 30, 2025[8, 15] - The company is financed until 2028 through key value inflection points[8] MP0712 Radio-DARPin Therapy - MP0712 induces complete and durable tumor regression in NCI-H82 tumor model at 10 µCi injected every week[27] - Phase 1 study is expected to start in H2 2025, with initial safety and efficacy data in 2026[32] MP0533 Tetra-specific T-cell Engager for AML - In DR 8, 3 of 8 evaluable patients responded after cycle 1: 1 CR and 2 CRh as best overall response[62] - In DR 1-7, 12% (4) patients had response rate, while in DR 8, 37.5% (3) patients had response rate[69]

Midland States Bancorp, Inc. Third Quarter 2025 Earnings Presentation October 30, 2025 Forward Looking Statement Forward-Looking Statements: Readers should note that in addition to the historical information contained herein, this press release includes "forward-looking statements" within the meanings of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to ...

Financial Performance - NorthWestern Energy reported GAAP diluted EPS of $0.62 and non-GAAP diluted EPS of $0.79 for the third quarter of 2025[8, 11] - The company is affirming its 2025 earnings guidance range of $3.53 - $3.65 per diluted share[11] - Operating revenues increased by $41.8 million, a 12.1% variance, from $345.2 million in Q3 2024 to $387.0 million in Q3 2025[17] - Utility Margin increased by $42.8 million, a 16.6% variance, from $257.3 million in Q3 2024 to $300.1 million in Q3 2025[17] - Net income decreased by $8.6 million, an 18.4% variance, from $46.8 million in Q3 2024 to $38.2 million in Q3 2025[17] Capital Investments and Growth - The company forecasts $2.74 billion of highly executable and low-risk capital investment over the next five years, expected to drive annualized earnings and rate base growth of approximately 4% - 6%[14] - No equity is expected to fund the current $2.74 billion 5-year capital plan[49, 53] Strategic Initiatives - NorthWestern Energy announced an agreement with Black Hills Corporation for an all-stock Merger of Equals and filed joint applications for transaction approval with regulatory commissions in Montana, Nebraska, and South Dakota[11] - The company submitted a 131 MW natural gas generation project in the Southwest Power Pool (SPP) expedited resource adequacy study, a project of approximately $300 million not included in the current five-year capex plan[11] Regulatory and Legal - The company filed a tariff waiver request with MPSC for recovery of operating costs associated with the Avista Colstrip interest[11]

Financial Performance - Net Income per diluted share for Q3 2025 was $2.56, compared to $1.84 in Q3 2024, primarily driven by gains on sale of real estate[9] - Core FFO per diluted share grew by 1.5% compared to Q3 2024, exceeding guidance midpoint by $0.03[9] - Same-property revenue and NOI grew by 2.7% and 2.4%, respectively, compared to Q3 2024[9] - The company revised its full-year Net Income guidance to a midpoint of $10.58 per diluted share, an increase of $0.41[6] - The company revised its full-year Total FFO guidance to a midpoint of $15.96 per diluted share, an increase of $0.07[6] - The company revised its full-year Core FFO guidance to a midpoint of $15.94 per diluted share, an increase of $0.03[6] Capital Structure and Liquidity - Total market capitalization is $24.5 billion as of September 30, 2025[10] - The company's capital structure consists of 73% equity, 23% unsecured debt, 3% secured debt, and 1% commercial paper and credit facility[11] - Total liquidity stands at $1.507 billion, including $1.380 billion in available unsecured commitments and $127 million in cash, cash equivalents, and marketable securities[12] Debt and Credit - The company increased its unsecured credit facility from $1.2 billion to $1.5 billion and extended the maturity date to January 2030[9] - The company amended its existing $300 million unsecured term loan to extend the maturity date to January 2031 and reduced the interest rate by 0.10% to SOFR plus 0.85%[9] - Debt to Total Assets is 34%[2]

Financial Performance - Q3 2025 adjusted EPS was $1.60, exceeding estimates by $0.10, and the full year 2025 adjusted EPS projection is $4.30[13] - Q3 2025 as-reported EPS was $1.55, compared to $1.40 in Q3 2024[15] - Year-to-date 2025 as-reported EPS was $3.56, compared to $3.53 in the same period of 2024[15] - Year-to-date 2025 adjusted EPS was $3.76, compared to $3.56 in the same period of 2024[15] Sales and Load Growth - Weather-normal retail electricity sales grew by 2.6% in Q3 2025 compared to the prior year[13] - Total retail electricity sales increased by 2.6% year-to-date in 2025[27] - Large load pipeline remains above 50GW across the system[13] - Contracts for 8GW of large load support long-term sales growth outlook, with an increase of 2GW in Q3[13, 30] Equity and Financing - Additional equity of $1.8 billion was priced, solidifying $7 billion of the $9 billion equity need[13] - An additional $5 billion in capital expenditure opportunities would require incremental equity of approximately 40%[13] - The company issued $257 million through internal equity plans through Q3 2025[36] Capital Investments and Resource Planning - The company projects $76 billion in capital expenditures from 2025-2029, with 95% allocated to state-regulated utilities[40] - Georgia Power filed for certification of 10GW of new resources through all-source and supplemental processes[47, 51] - Up to $5 billion of additional regulated capital investment opportunities remain, including up to $4 billion tied to Georgia Power-owned resources and $1 billion in expansion opportunities at FERC-regulated businesses[57, 58] Debt and Liquidity - Over $8.9 billion in committed credit facilities and available liquidity of $10.6 billion as of September 30, 2025[72]

Financial Performance & Growth - Hitachi Energy's H1 2025 revenue reached $9.2 billion, a 26% increase compared to $7.3 billion in 2024[5] - Adjusted EBITA increased from 10.6% in 2024 to 12.9% in 2025[6] - ROIC accelerated from 16.7% in 2024 to 41.7% in 2025[7] - The company projects revenue to reach $33 billion+ by 2030, with a CAGR of 13-15% from 2024-2030[66] - Hitachi Energy aims for an Adjusted EBITA margin of 16-20% and ROIC of 25-30% by 2030[66, 114] Market & Strategy - Global electricity demand is projected to increase over 70% by 2035[22] - Renewables are expected to represent 50% of global installed power generation capacity by 2030, up from 28% today[31] - Hitachi Energy is the 1 market share leader in Grid Automation, Grid Integration, Transformers, and High Voltage (HVDC & Power Quality) sectors[17] - The company has a $50 billion order backlog in FY2025, reflecting strong market demand[69] - Hitachi Energy plans to invest over $1 billion in its service business between 2025 and 2030[204]

Financial Performance & Outlook - 3Q25 Core FFO per share增长0.4%，年初至今增长2.3%[9] - 3Q25 Same Store Residential Revenue增长2.3%，年初至今增长2.7%[9] - 2025全年Core FFO per share增长预期中点为2.2%，低于先前预期的3.5%[29] - 2025全年Same Store Residential Revenue增长预期为2.5%，低于先前预期的2.8%和初始预期的3.0%[29] - 运营费用增长预期上调，当前预期为3.8%，高于先前预期的3.1%和初始预期的4.1%[29] Capital Allocation & Development - 2025年至今已筹集20亿美元资本[9] - 30亿美元的开发项目正在进行中，预计稳定后将带来增量收益和价值创造[8] - 股票回购金额为1.5亿美元，加权平均股价为193美元[9] - 开发启动金额为4.35亿美元，年初至今为10亿美元[9] Strategic Focus - 2025年战略重点领域取得重大进展，增加了郊区和扩张区域的配置[8] - 预计2025年运营举措带来的增量NOI为900万美元，已完成超过8000万美元的运行率增量NOI的一半[8]

Financial Performance - Westlake Corporation's net sales for 3Q 2025 were $2838 million, a decrease of 9% year-over-year from $3117 million in 3Q 2024[6, 25] - The company's EBITDA for 3Q 2025 was $313 million, a 46% decrease compared to $580 million in 3Q 2024[5, 6] - Westlake reported a net loss attributable to the company of $782 million for 3Q 2025, compared to a net income of $108 million in 3Q 2024[25, 27] - The company achieved approximately $115 million in company-wide cost savings year-to-date, including $40 million in 3Q 2025, toward its fiscal year 2025 target of $150 - $175 million[6] Segment Performance - Housing and Infrastructure Products (HIP) - HIP segment sales for 3Q 2025 were $1091 million, a 1% decrease compared to $1098 million in 3Q 2024[10, 25] - HIP segment EBITDA for 3Q 2025 was $215 million, an 18% decrease compared to $262 million in 3Q 2024[6, 10] - The company expects 2025 revenue and EBITDA margin for the HIP segment to be at the low ends of the previously communicated ranges of $4200 - $4400 million of sales with a 20% - 22% EBITDA margin[11] Segment Performance - Performance and Essential Materials (PEM) - PEM segment sales for 3Q 2025 were $1747 million, a 13% decrease compared to $2019 million in 3Q 2024[15, 25] - PEM segment EBITDA for 3Q 2025 was $90 million, a 70% decrease compared to $297 million in 3Q 2024[6, 15] - PEM EBITDA includes an estimated $32 million unfavorable FIFO impact[18] Strategic Initiatives - Westlake is progressing towards $200 million of identified cost savings in 2026, in addition to a footprint optimization benefit of approximately $100 million in 2026 from the Pernis shutdown[5] - The company is taking action to achieve $200 million of company-wide identified cost savings in 2026 with the majority of that occurring in the PEM segment[22]

Financial Performance - Net Income per diluted share was $0.12 in 3Q 2025, a 100% increase compared to $0.06 in 3Q 2024[8] - FFO per diluted share was $0.62 in 3Q 2025, a 3% increase compared to $0.60 in 3Q 2024[8] - FFOA per diluted share was $0.65 in 3Q 2025, a 5% increase compared to $0.62 in 3Q 2024[8] - The company raised its full-year 2025 guidance for Net Income and FFOA per diluted share by $0.02 to a midpoint of $0.58 and $2.54, respectively[11] - Total revenue increased by $11.7 million YOY, or 2.8%, to $431.9 million in 3Q 2025[12] Same-Store Results - Same-Store revenue grew by 2.6% YOY in 3Q 2025[9] - Same-Store expense increased by 3.1% YOY in 3Q 2025[9] - Same-Store NOI grew by 2.3% YOY in 3Q 2025[9] - Physical occupancy for Same-Store communities was 96.6% in 3Q 2025, a 0.3% increase YOY[16] - The company updated its full-year 2025 Same-Store revenue growth guidance to 2.20% to 2.60%, a 0.10% decrease from the prior midpoint[11] Capital Activities - The company repurchased approximately 651 thousand shares of its common stock for $25.0 million during 3Q 2025 and an additional 277 thousand shares for $10.0 million subsequent to quarter-end[9] - The company extended the maturity date of its $350.0 million senior unsecured term loan from January 31, 2027, to January 31, 2029[9] - Total indebtedness as of September 30, 2025, was $5.8 billion, with $485.9 million, or 8.9%, maturing through 2026[24]